Formycon AG (LTS:0W4N)
€ 54.6 0.9 (1.68%) Market Cap: 964.48 Mil Enterprise Value: 934.72 Mil PE Ratio: 13.14 PB Ratio: 1.62 GF Score: 75/100

Q3 2024 Formycon AG Earnings Call Transcript

Nov 28, 2024 / 02:00PM GMT
Release Date Price: €50 (+2.77%)
Stefan Glombitza
Formycon AG - Chief Executive Officer, Member of the Executive Board

Thank you very much for the kind introduction. Dear ladies and gentlemen, warm welcome on behalf of the complete Formycon Management Board to our earnings call. We appreciate your interest. Those ones who have read potentially our press release earlier this morning can already confirm that we are looking at encouraging numbers for the first nine months in this year.

In summary, we have a very strong operational performance with multiple highlights, and we are also looking at robust financial key indicator. Enno Spinner, our CFO, and me will be happy to guide you through the details of the nine months performance.

As always, in those settings, we want to remind you that our presentation contains forward-looking statements, which are based on our current assumptions and might be subject to change if unexpected risks or uncertainties materialize. There's still too many patients with severe diseases that are heavily underserved with biologics. And it's our mission as Formycon to change that. and to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot